Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Strasser

Showing results (151-160 of 320) with videos related to

Pageof 32
Sort By:
Cell Death and Differentiation|June 20, 2020
Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cellsRachel Thijssen, Silvia Alvarez-Diaz, Clea Grace, et al.
EMBO Reports|December 15, 2010
Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein BimDiane Moujalled, Ross Weston, Holly Anderton, et al.
The EMBO Journal|June 27, 2022
The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOKFrancine S Ke, Steven Holloway, Rachel T Uren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Antigen challenge inhibits thymic emigrationAdam P Uldrich, Stuart P Berzins, Mark A Malin, et al.
Cell Reports|May 14, 2013
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and NoxaLiz J Valente, Daniel H D Gray, Ewa M Michalak, et al.
Blood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Journal of Experimental Medicine|October 9, 2002
Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by BimGayle M Davey, Christian Kurts, Jacques F A P Miller, et al.
Diabetes|February 7, 2008
Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cellsMark D McKenzie, Emma M Carrington, Thomas Kaufmann, et al.
Biology of Reproduction|February 28, 2014
Loss of the proapoptotic BH3-only protein BCL-2 modifying factor prolongs the fertile life span in female miceSeng H Liew, Kavitha Vaithiyanathan, Michele Cook, et al.
The Journal of Experimental Medicine|August 12, 2017
PTPN2 regulates T cell lineage commitment and αβ versus γδ specificationFlorian Wiede, Jarrod A Dudakov, Kun-Hui Lu, et al.
Pageof 32

Showing results (151-160 of 320) with videos related to

Sort By:
Pageof 32
Cell Death and Differentiation|June 20, 2020
Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cellsRachel Thijssen, Silvia Alvarez-Diaz, Clea Grace, et al.
EMBO Reports|December 15, 2010
Cyclic-AMP-dependent protein kinase A regulates apoptosis by stabilizing the BH3-only protein BimDiane Moujalled, Ross Weston, Holly Anderton, et al.
The EMBO Journal|June 27, 2022
The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOKFrancine S Ke, Steven Holloway, Rachel T Uren, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2006
Antigen challenge inhibits thymic emigrationAdam P Uldrich, Stuart P Berzins, Mark A Malin, et al.
Cell Reports|May 14, 2013
p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and NoxaLiz J Valente, Daniel H D Gray, Ewa M Michalak, et al.
Blood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.
The Journal of Experimental Medicine|October 9, 2002
Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by BimGayle M Davey, Christian Kurts, Jacques F A P Miller, et al.
Diabetes|February 7, 2008
Proapoptotic BH3-only protein Bid is essential for death receptor-induced apoptosis of pancreatic beta-cellsMark D McKenzie, Emma M Carrington, Thomas Kaufmann, et al.
Biology of Reproduction|February 28, 2014
Loss of the proapoptotic BH3-only protein BCL-2 modifying factor prolongs the fertile life span in female miceSeng H Liew, Kavitha Vaithiyanathan, Michele Cook, et al.
The Journal of Experimental Medicine|August 12, 2017
PTPN2 regulates T cell lineage commitment and αβ versus γδ specificationFlorian Wiede, Jarrod A Dudakov, Kun-Hui Lu, et al.
Pageof 32